日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

吡托布替尼与伊布替尼治疗初治及复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的比较

Woyach, Jennifer A; Qiu, Lugui; Grosicki, Sebastian; Wrobel, Tomasz; Capra, Marcelo; Czyz, Jaroslaw; Yi, Shuhua; Eom, Ki-Seong; Panovská, Anna; Jurczak, Wojciech; Laribi, Kamel; Jacobasch, Lutz; Baker, Ross; Agajanian, Richy; Berkovits, Alejandro; Özcan, Muhit; Lepretre, Stéphane; Coombs, Catherine C; Cramer, Paula; Lewis, Katharine L; Hill, Marisa; Bao, Katherine; Bian, Yuanyuan; De Batista Ribeiro, Silvia Ramalho; Bhandari, Naleen Raj; Ruppert, Amy S; Leow, Ching Ching; Wierda, William G

Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)

晚期胰腺腺癌患者二线化疗总生存期和治疗持续时间的预测标准(AIO-PAK-0216)

Lutz, Manfred P; Ansorge, Nikolaus; Barmashenko, Gleb; Bauer, Hans; Burkart, Christof; Decker, Thomas; Ettrich, Thomas; Fischer von Weikersthal, Ludwig; Geer, Thomas; Gerhardt, Anke; Höfling, Sabine; Jacobasch, Lutz; Koenigsmann, Michael; Leidig, Tobias; Plentz, Ruben; Räth, Sebastian; Reichert, Dietmar; Schulte, Markos; Schulte, Nadine; Schwarzer, Andreas; Siegler, Gabriele; Waldschmidt, Dirk; Karthaus, Meinolf

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE

一项前瞻性研究对超过 600 例接受一线帕尼单抗联合 FOLFIRI/FOLFOX 方案治疗的 RAS 野生型转移性结直肠癌患者进行了改良转移性结直肠癌评分 (mCCS) 的验证:非干预性研究 VALIDATE 的最终结果

Potthoff, Karin; Uhlig, Jens; Jacobasch, Lutz; Müller, Lothar; Reiser, Marcel; de Buhr, Rebecca; Polata, Silke; Gerger, Armin; Zehrer, Viktor; Amann, Arno; Göhler, Thomas; Serrer, Laura; Schröder, Jan; Semsek, Dieter; Köhler, Andreas; Stübs, Patrick; Prager, Gerald; Siebenbach, Hans Ulrich; Schuch, Anita; Marschner, Norbert

End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia

一线慢性淋巴细胞白血病终点替代指标

Simon, Florian; Ligtvoet, Rudy; Robrecht, Sandra; Cramer, Paula; Kutsch, Nadine; Fürstenau, Moritz; Goede, Valentin; von Tresckow, Julia; Langerbeins, Petra; Fink, Anna-Maria; Huber, Henriette; Tausch, Eugen; Schneider, Christof; Wendtner, Clemens M; Ritgen, Matthias; Dreyling, Martin; Müller, Lothar; Jacobasch, Lutz; Heinz, Werner J; Vehling-Kaiser, Ursula; Sivcheva, Liliya; Böttcher, Sebastian; Dreger, Peter; Illmer, Thomas; Gregor, Michael; Staber, Philipp B; Stilgenbauer, Stephan; Niemann, Carsten U; Kater, Arnon P; Fischer, Kirsten; Eichhorst, Barbara; Hallek, Michael; Al-Sawaf, Othman

Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy

炎症应激决定接受靶向治疗和免疫治疗的HER2阳性食管胃腺癌患者是否需要化疗

Tintelnot, Joseph; Paschold, Lisa; Goekkurt, Eray; Schultheiss, Christoph; Matschl, Urte; Santos Cruz, Mariana; Bauer, Marcus; Wickenhauser, Claudia; Thuss-Patience, Peter; Lorenzen, Sylvie; Ettrich, Thomas J; Riera-Knorrenschild, Jorge; Jacobasch, Lutz; Kretzschmar, Albrecht; Kubicka, Stefan; Al-Batran, Salah-Eddin; Reinacher-Schick, Anke; Pink, Daniel; Bokemeyer, Carsten; Sinn, Marianne; Lindig, Udo; Hinke, Axel; Hegewisch-Becker, Susanna; Stein, Alexander; Binder, Mascha

Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine

鲁索替尼治疗骨髓纤维化的大型非干预性4期临床常规研究的最终结果

Koschmieder, Steffen; Isfort, Susanne; Schulte, Clemens; Jacobasch, Lutz; Geer, Thomas; Reiser, Marcel; Koenigsmann, Michael; Heinrich, Bernhard; Wehmeyer, Jürgen; von der Heyde, Eyck; Tesch, Hans; Gröschl, Benedikt; Bachhuber, Petra; Großer, Susanne; Koehler, Michael; Pahl, Heike L

Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)

纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸钙或吉西他滨联合顺铂治疗晚期胆管癌:AIO肝胆-YMO癌症组的II期研究(NIFE-AIO-YMO HEP-0315)

Ettrich, Thomas J; Modest, Dominik P; Sinn, Marianne; Striefler, Jana K; Opitz, Bernhard; Goetze, Thorsten; Gallmeier, Eike; Angermeier, Stefan; Fischer von Weikersthal, Ludwig; Jacobasch, Lutz; Waldschmidt, Dirk; Niedermeier, Michael; Sohm, Michael; Berger, Andreas W; Manzini, Giulia; Fehrenbach, Uli; Auer, Timo Alexander; Hosse, Clarissa; Vogele, Daniel; Sookthai, Disorn; Schaaf, Marina; Muche, Rainer; Hinke, Axel; Seufferlein, Thomas; Perkhofer, Lukas

Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial

鲁索替尼治疗骨髓纤维化的真实世界分析:JAKoMo非干预性IV期试验中既往未接受过JAK抑制剂治疗的患者的中期结果

Koschmieder, Steffen; Isfort, Susanne; Schulte, Clemens; Jacobasch, Lutz; Geer, Thomas; Reiser, Marcel; Koenigsmann, Michael; Heinrich, Bernhard; Wehmeyer, Jürgen; von der Heyde, Eyck; Tesch, Hans; Gröschl, Benedikt; Bachhuber, Petra; Großer, Susanne; Pahl, Heike L

Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial

伊匹木单抗联合纳武利尤单抗和曲妥珠单抗治疗既往未接受治疗的ERBB2阳性食管胃腺癌患者的疗效:AIO INTEGA随机临床试验

Stein, Alexander; Paschold, Lisa; Tintelnot, Joseph; Goekkurt, Eray; Henkes, Svenja-Sibylla; Simnica, Donjete; Schultheiss, Christoph; Willscher, Edith; Bauer, Marcus; Wickenhauser, Claudia; Thuss-Patience, Peter; Lorenzen, Sylvie; Ettrich, Thomas; Riera-Knorrenschild, Jorge; Jacobasch, Lutz; Kretzschmar, Albrecht; Kubicka, Stefan; Al-Batran, Salah-Eddin; Reinacher-Schick, Anke; Pink, Daniel; Sinn, Marianne; Lindig, Udo; Hiegl, Wolfgang; Hinke, Axel; Hegewisch-Becker, Susanna; Binder, Mascha

Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera

真实世界中的细胞减灭治疗:对 1440 例真性红细胞增多症患者的病历回顾分析

Crodel, Carl C; Jentsch-Ullrich, Kathleen; Reiser, Marcel; Jacobasch, Lutz; Sauer, Annette; Tesch, Hans; Ulshöfer, Thomas; Wunschel, Regine; Palandri, Francesca; Heidel, Florian H